Analyzing cancer cells in blood and tissue to improve disease detection and monitoring
Ultra-high content analyses of circulating and solid tumor cells: A diagnostic reference system for disease burden
['FUNDING_SBIR_2'] · QUANTITATIVE IMAGING SYSTEMS, LLC · NIH-10704738
This study is working on new imaging technology to take a closer look at cancer cells in both blood and tumors, which could help doctors find cancer earlier and understand how well treatments are working for patients like you.
Quick facts
| Phase | ['FUNDING_SBIR_2'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | QUANTITATIVE IMAGING SYSTEMS, LLC (nih funded) |
| Locations | 1 site (MONROEVILLE, UNITED STATES) |
| Trial ID | NIH-10704738 on ClinicalTrials.gov |
What this research studies
This research aims to develop advanced imaging technology that allows for detailed analysis of cancer cells both in blood and within solid tumors. By utilizing a modular suite of products, the project will create a platform for highly multiplexed imaging and quantitative analysis of individual cells, helping to establish disease status and track treatment responses. The approach focuses on linking cellular features from tissue-resident cancer cells to those circulating in the bloodstream, which could lead to earlier detection of cancer and better prognostic information for patients. The research will also involve collaboration with Oregon Health and Science University to ensure clinical relevance and application.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with various types of cancer, particularly those with rectal cancer or other malignancies.
Not a fit: Patients with non-malignant conditions or those not diagnosed with cancer may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a non-invasive method for monitoring cancer progression and treatment response, improving patient outcomes.
How similar studies have performed: Other research has shown promise in using advanced imaging techniques for cancer detection, indicating that this approach could be a significant advancement in the field.
Where this research is happening
MONROEVILLE, UNITED STATES
- QUANTITATIVE IMAGING SYSTEMS, LLC — MONROEVILLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: NEDERLOF, MICHEL — QUANTITATIVE IMAGING SYSTEMS, LLC
- Study coordinator: NEDERLOF, MICHEL
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers, neoplasm/cancer